Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.

Laza-Briviesca R, Cruz-Bermúdez A, Nadal E, Insa A, García-Campelo MDR, Huidobro G, Dómine M, Majem M, Rodríguez-Abreu D, Martínez-Martí A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Massuti B, Casarrubios M, Sierra-Rodero B, Tarín C, García-Grande A, Haymaker C, Wistuba II, Romero A, Franco F, Provencio M

Open source

DOI: 10.1002/ctm2.491
Published: 2021 Jul
Container: Clinical and translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.491,
  title = {Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.},
  author = {Laza-Briviesca R and Cruz-Bermúdez A and Nadal E and Insa A and García-Campelo MDR and Huidobro G and Dómine M and Majem M and Rodríguez-Abreu D and Martínez-Martí A and De Castro Carpeño J and Cobo M and López Vivanco G and Del Barco E and Bernabé Caro R and Viñolas N and Barneto Aranda I and Viteri S and Massuti B and Casarrubios M and Sierra-Rodero B and Tarín C and García-Grande A and Haymaker C and Wistuba II and Romero A and Franco F and Provencio M},
  year = {2021},
  journal = {Clinical and translational medicine},
  doi = {10.1002/ctm2.491},
  url = {https://doi.org/10.1002/ctm2.491}
}

RIS

TY  - JOUR
TI  - Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
AU  - Laza-Briviesca R
AU  - Cruz-Bermúdez A
AU  - Nadal E
AU  - Insa A
AU  - García-Campelo MDR
AU  - Huidobro G
AU  - Dómine M
AU  - Majem M
AU  - Rodríguez-Abreu D
AU  - Martínez-Martí A
AU  - De Castro Carpeño J
AU  - Cobo M
AU  - López Vivanco G
AU  - Del Barco E
AU  - Bernabé Caro R
AU  - Viñolas N
AU  - Barneto Aranda I
AU  - Viteri S
AU  - Massuti B
AU  - Casarrubios M
AU  - Sierra-Rodero B
AU  - Tarín C
AU  - García-Grande A
AU  - Haymaker C
AU  - Wistuba II
AU  - Romero A
AU  - Franco F
AU  - Provencio M
PY  - 2021
JO  - Clinical and translational medicine
DO  - 10.1002/ctm2.491
UR  - https://doi.org/10.1002/ctm2.491
ER  -

APA

R, L., A, C., E, N., A, I., MDR, G., G, H., M, D., M, M., D, R., A, M., J, D. C. C., M, C., G, L. V., E, D. B., R, B. C., N, V., I, B. A., S, V., B, M., M, C., B, S., C, T., A, G., C, H., II, W., A, R., F, F., & M, P. (2021). Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.491

Source records

pubmed · retrieved 2026-09-26T18:33:28.445Z